After Roller Coaster Year, Yidu Stock Settles Down Post-IPO
Big-data healthcare services provider’s operating loss widened in its latest reporting period as revenue grew 62% Key Takeaways: Yidu’s revenue rose 62% in the six months through SeptemberCompany’s health management…
Recent Articles
RELATED ARTICLES
-
Yidu suffers from lingering Covid chill
2158.HK
- Margins ring alarm bells as 160 Health readies IPO
-
Ping An Health pins recovery hopes on new leadership
1833.HK
-
Profits recover at Alibaba Health but prognosis unclear
0241.HK
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
- CHINA BULLETIN: Janet Yellen’s Awkward Beijing Visit
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
Discover hidden China stock gems in our weekly newsletter